Patents by Inventor Jingye Lu

Jingye Lu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-HER3 humanized monoclonal antibody
    Patent number: 11965037
    Abstract: Provided is an anti-HER3 humanized monoclonal antibody. The antibody binds HER3 antigen, has high affinity and biological activity and low immunogenicity, and is stable in structure. The antibody can be used for preparing drugs for preventing or treating HER3-related diseases.
    Type: Grant
    Filed: July 17, 2019
    Date of Patent: April 23, 2024
    Assignee: SHANGHAI INSTITUTE OF BIOLOGICAL PRODUCTS CO., LTD.
    Inventors: Aidong Qu, Hongyuan Liang, Fanhong Xu, Aoxiang Li, Lina Wu, Jingye Zhu, Jianhua Qiu, Jin Lu, Lin Zhang, Xin Zhao, Xiaofei Song
  • Combined vaccine against both HAV and measles virus and method of producing it
    Patent number: 6562350
    Abstract: A combined hepatitis A-measles live vaccine, its lyophilized formulations with enhanced storage stability and methods of preparing the same by mixing the viral stocks of hepatitis A virus and measles virus or by propagating the two viruses on same diploid cell substrate are disclosed. The combined live vaccine thus prepared is a useful vaccine for preventing the infections with hepatitis A and measles without causing any interference between antigenicity of the two viruses and any serious adverse events due to their mixing or co-culturing.
    Type: Grant
    Filed: July 6, 2001
    Date of Patent: May 13, 2003
    Assignee: Changchun Institute of Biological Products, Ministry of Public Health
    Inventors: Pengfu Wang, Jingye Lu, Guangpu Li, Baosheng Xie, Zongming Song, Shuyan Li